Bayer AG, the second largest consumer health company in the world in 2013, continues its strong market performance in “over the counter” (OTC) drugs, vitamins and dietary supplements with its broad portfolio and iconic brands.
The company has made progress towards its goal of becoming the global leader through recent high-profile acquisitions, solid organic growth and expansion in emerging markets. However, considerable merger activity in the industry presents new formidable challengers.
Euromonitor International’s Bayer AG in Consumer Health (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry.
The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.